{
    "2019-09-25": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Protalix Completes Enrollment in Third Fabry Disease Study",
                "features": {
                    "keywords": [
                        "Protalix",
                        "Fabry Disease",
                        "Study",
                        "Enrollment"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "China",
                        "demand",
                        "drugs",
                        "growth"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}